Skip to main content
Top
Published in: Acta Neuropathologica 2/2015

01-02-2015 | Editorial

Protein aggregation in Alzheimer’s disease: Aβ and τ and their potential roles in the pathogenesis of AD

Authors: Dietmar Rudolf Thal, Marcus Fändrich

Published in: Acta Neuropathologica | Issue 2/2015

Login to get access

Excerpt

This issue of Acta Neuropathologica includes a cluster of three review papers focusing on amyloid β-peptide (Aβ) and/or τ-protein aggregates in Alzheimer’s disease (AD). Since the first description of the disease by Alzheimer [1], Aβ-containing amyloid plaques and τ-derived neurofibrillary tangles (NFTs) have been identified to represent the pathological hallmarks of AD [1, 6, 8]. These two types of protein aggregates share a number of biochemical features. Both form fibrils, which are the major compounds of amyloid plaques (Aβ fibrils) and neurofibrillary tangles (τ fibrils; NFTs). Both proteins were shown to undergo posttranslational modifications, such as phosphorylation, truncation and/or pyroglutamate formation in the AD brain. These modifications may accelerate the speed of aggregation in vitro. Moreover, Aβ has been shown to promote τ aggregation [5, 7], suggesting that protein aggregation represents a key starter and/or promoter of the disease. The ability of Aβ to functionally interact with τ may depend on other proteins such as N-methyl-d-aspartate (NMDA) receptors that act as molecular switches to induce neuronal dysfunction and neurodegeneration. Figure 1 provides a schematic representation of the roles of Aβ and τ as presented in this cluster. The clinical manifestation of AD is, thereby, associated with high levels of mature Aβ and τ aggregates widely distributed throughout the brain.
Literature
1.
go back to reference Alzheimer A (1907) Ueber eine eigenartige Erkrankung der Hirnrinde. Allg Zschr Psych 64:146–148 Alzheimer A (1907) Ueber eine eigenartige Erkrankung der Hirnrinde. Allg Zschr Psych 64:146–148
2.
go back to reference Bancher C, Brunner C, Lassmann H, Budka H, Jellinger K, Wiche G, Seitelberger F, Grundke-Iqbal I, Iqbal K, Wisniewski HM (1989) Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer’s disease. Brain Res 477:90–99PubMedCrossRef Bancher C, Brunner C, Lassmann H, Budka H, Jellinger K, Wiche G, Seitelberger F, Grundke-Iqbal I, Iqbal K, Wisniewski HM (1989) Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer’s disease. Brain Res 477:90–99PubMedCrossRef
3.
go back to reference Braak E, Braak H, Mandelkow EM (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 87:554–567PubMedCrossRef Braak E, Braak H, Mandelkow EM (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 87:554–567PubMedCrossRef
4.
go back to reference Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259PubMedCrossRef Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259PubMedCrossRef
5.
go back to reference Götz J, Chen F, van Dorpe J, Nitsch RM (2001) Formation of neurofibrillary tangles in P301 l tau transgenic mice induced by Abeta 42 fibrils. Science 293:1491–1495PubMedCrossRef Götz J, Chen F, van Dorpe J, Nitsch RM (2001) Formation of neurofibrillary tangles in P301 l tau transgenic mice induced by Abeta 42 fibrils. Science 293:1491–1495PubMedCrossRef
6.
go back to reference Grundke-Iqbal I, Iqbal K, Quinlan M, Tung YC, Zaidi MS, Wisniewski HM (1986) Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem 261:6084–6089PubMed Grundke-Iqbal I, Iqbal K, Quinlan M, Tung YC, Zaidi MS, Wisniewski HM (1986) Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem 261:6084–6089PubMed
7.
go back to reference Lasagna-Reeves CA, Castillo-Carranza DL, Guerrero-Muoz MJ, Jackson GR, Kayed R (2010) Preparation and characterization of neurotoxic tau oligomers. Biochemistry 49:10039–10041PubMedCrossRef Lasagna-Reeves CA, Castillo-Carranza DL, Guerrero-Muoz MJ, Jackson GR, Kayed R (2010) Preparation and characterization of neurotoxic tau oligomers. Biochemistry 49:10039–10041PubMedCrossRef
8.
go back to reference Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci 82:4245–4249PubMedCentralPubMedCrossRef Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci 82:4245–4249PubMedCentralPubMedCrossRef
9.
go back to reference Sassin I, Schultz C, Thal DR, Rüb U, Arai K, Braak E, Braak H (2000) Evolution of Alzheimer’s disease-related cytoskeletal changes in the basal nucleus of Meynert. Acta Neuropathol (Berl) 100:259–269CrossRef Sassin I, Schultz C, Thal DR, Rüb U, Arai K, Braak E, Braak H (2000) Evolution of Alzheimer’s disease-related cytoskeletal changes in the basal nucleus of Meynert. Acta Neuropathol (Berl) 100:259–269CrossRef
10.
go back to reference Thal DR, Rüb U, Orantes M, Braak H (2002) Phases of Abeta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791–1800PubMedCrossRef Thal DR, Rüb U, Orantes M, Braak H (2002) Phases of Abeta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791–1800PubMedCrossRef
Metadata
Title
Protein aggregation in Alzheimer’s disease: Aβ and τ and their potential roles in the pathogenesis of AD
Authors
Dietmar Rudolf Thal
Marcus Fändrich
Publication date
01-02-2015
Publisher
Springer Berlin Heidelberg
Published in
Acta Neuropathologica / Issue 2/2015
Print ISSN: 0001-6322
Electronic ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-015-1387-2

Other articles of this Issue 2/2015

Acta Neuropathologica 2/2015 Go to the issue